Octagon Capital Advisors LP / DYN
Octagon Capital Advisors LP’s Dyne Therapeutics Inc Position
Does Octagon Capital Advisors LP own Dyne Therapeutics Inc (DYN)? Not currently — the last reported position was 668.0K shares worth $16M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$16M
Q4 2024
Shares
668.0K
% of Portfolio
+2.59%
Quarters Held
14
position exited
Position History DYN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2024 | 668.0K | $16M | +2.59% |
| Q3 2024 | 262.7K | $9M | +1.47% |
| Q2 2024 | 1.18M | $42M | +6.55% |
| Q1 2024 | 1.24M | $35M | +4.23% |
| Q4 2023 | 792.9K | $11M | +1.69% |
| Q3 2023 | 692.9K | $6M | +0.95% |
| Q2 2023 | 692.9K | $8M | +1.08% |
| Q1 2023 | 692.9K | $8M | +1.15% |
| Q1 2022 | 525.3K | $5M | +1.09% |
| Q4 2021 | 583.6K | $7M | +1.35% |
| Q3 2021 | 583.6K | $9M | +2.33% |
| Q2 2021 | 583.6K | $12M | +2.54% |
| Q1 2021 | 583.6K | $9M | +3.41% |
| Q4 2020 | 481.5K | $10M | +3.51% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of DYN.